TRVI
Trevi Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD18.18
+1.41 (+8.41%)
Rating:C
Company Profile
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$17.14
Prev. Close
$16.77
Day Low
$17.01
Day High
$18.26
52W Low
$6.55
52W High
$20.22
Market Cap
$2.58B
Volume
2.20M